Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

被引:209
作者
Stasi, Roberto [1 ]
Sarpatwari, Ameet [2 ]
Segal, Jodi B. [3 ]
Osborn, John [4 ]
Evangelista, Maria Laura [1 ]
Cooper, Nichola [5 ]
Provan, Drew [6 ]
Newland, Adrian [6 ]
Amadori, Sergio [7 ]
Bussel, James B. [8 ]
机构
[1] Regina Apostolorum Hosp, Dept Med Sci, I-00041 Albano Laziale, Italy
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[3] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD USA
[4] Univ Roma La Sapienza, Dept Publ Hlth Sci, Rome, Italy
[5] Inst Child Hlth, Mol Immunol Unit, London, England
[6] Barts & London Queen Marys Sch Med & Dent, Dept Haematol, London, England
[7] Tor Vergata Univ Hosp, Dept Hematol, Rome, Italy
[8] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Div Hematol Oncol,Dept Pediat, Ithaca, NY 14853 USA
关键词
PLATELET RECOVERY; CAGA PROTEIN; B-CELL; THERAPY; EFFICACY; COUNT; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; EXPERIENCE;
D O I
10.1182/blood-2008-07-167155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Whether the eradication of Helicobacter pylori infection can increase the platelet count in patients with immune thrombocytopenic purpura (ITP) is still a controversial issue. To provide evidence-based guidance, we performed a systematic review of the literature published in English, selecting articles reporting 15 or more total patients. We identified 25 studies including 1555 patients, of whom 696 were evaluable for the effects of H pylori eradication on platelet count. The weighted mean complete response (platelet count >= 100 x 10(9)/L) and overall response (platelet count >= 30 x 10(9)/L and at least doubling of the basal count) were 42.7% (95% confidence interval [CI], 31.8%-53.9%) and 50.3% (95% CI, 41.6%-59.0%), respectively. In 222 patients with a baseline platelet count less than 30 x 10(9)/L, the complete response rate was 20.1% (95% CI, 13.5%-26.7%) and the overall response rate was 35.2% (95% CI, 28.0%-42.4%). The response rate tended to be higher in countries with a high background prevalence of H pylori infection and in patients with milder degrees of thrombocytopenia. These findings suggest that the detection and eradication of H pylori infection should be considered in the work-up of patients with seemingly typical ITP. (Blood. 2009; 113: 1231-1240)
引用
收藏
页码:1231 / 1240
页数:10
相关论文
共 56 条
  • [31] Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells
    Keates, A. C.
    Tummala, S.
    Peek, R. M., Jr.
    Csizmadia, E.
    Kunzli, B.
    Becker, K.
    Correa, P.
    Romero-Gallo, J.
    Piazuelo, M. B.
    Sheth, S.
    Kelly, C. P.
    Robson, S. C.
    Keates, S.
    [J]. INFECTION AND IMMUNITY, 2008, 76 (09) : 3992 - 3999
  • [32] Kodama M, 2007, HELICOBACTER, V12, P36, DOI 10.1111/j.1523-5378.2007.00477.x
  • [33] Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura
    Kohda, K
    Kuga, T
    Kogawa, K
    Kanisawa, Y
    Koike, K
    Kuroiwa, G
    Hirayama, Y
    Sato, Y
    Niitsu, Y
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 584 - 588
  • [34] Measurement of observer agreement
    Kundel, HL
    Polansky, M
    [J]. RADIOLOGY, 2003, 228 (02) : 303 - 308
  • [35] ABC of the upper gastrointestinal tract - Epidemiology and diagnosis of Helicobacter pylori infection
    Logan, RPH
    Walker, MM
    [J]. BRITISH MEDICAL JOURNAL, 2001, 323 (7318): : 920 - 922
  • [36] Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
    Malfertheiner, P.
    Megraud, F.
    O'Morain, C.
    Bazzoli, F.
    El-Omar, E.
    Graham, D.
    Hunt, R.
    Rokkas, T.
    Vakil, N.
    Kuipers, E. J.
    [J]. GUT, 2007, 56 (06) : 772 - 781
  • [37] Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?
    Michel, M
    Cooper, N
    Jean, C
    Frissora, C
    Bussel, JB
    [J]. BLOOD, 2004, 103 (03) : 890 - 896
  • [38] The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura
    Nomura, S
    Inami, N
    Kanazawa, S
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (04) : 304 - 305
  • [39] Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections
    Paziak-Domanska, B
    Chmiela, M
    Jarosinska, A
    Rudnicka, W
    [J]. CELLULAR IMMUNOLOGY, 2000, 202 (02) : 136 - 139
  • [40] PerezPerez GI, 1997, INT J CANCER, V72, P453, DOI 10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO